# Mark A. Kay

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-a-kay/

## Facts

| Field | Value |
| --- | --- |
| Citations | 50,189 |
| Field | Virus-based gene therapy research |
| h-index | 113 |
| i10-index | 279 |
| Last Known Institution | Io Therapeutics (United States) |
| OpenAlex ID | https://openalex.org/A5027557554 |
| ORCID iD | https://orcid.org/0000-0002-2799-2615 |
| Works | 417 |

## Researcher papers

- [Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response](https://scholariq.org/papers/successful-transduction-of-liver-in-hemophilia-by-aav-factor-ix-and-limitations/)

## Researcher topics

- [Virus-based gene therapy research](https://scholariq.org/topics/virus-based-gene-therapy-research-2/)
- [CRISPR and Genetic Engineering](https://scholariq.org/topics/crispr-and-genetic-engineering/)
- [RNA Interference and Gene Delivery](https://scholariq.org/topics/rna-interference-and-gene-delivery/)
- [Viral Infectious Diseases and Gene Expression in Insects](https://scholariq.org/topics/viral-infectious-diseases-and-gene-expression-in-insects-2/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Researcher university

- [Io Therapeutics (United States)](https://scholariq.org/institutions/io-therapeutics-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.